Exploration of the Causal Relationship and Mechanisms Between Serum Albumin and Venous Thrombosis: a Bidirectional Mendelian Randomization Analysis and Bioinformatics Study

Overview

Journal Thromb J

Publisher Biomed Central

Date 2025 Mar 3

PMID 40033322

Authors

Xuemei Xia

Xin Tie

Maolin Hong

Wanhong Yin

Affiliations

Soon will be listed here.

Abstract

Background: To explore the causal relationship between serum albumin and venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and its consequential condition, pulmonary embolism (PE), through Mendelian randomization (MR) design, seeking to clarify the protective roles of albumin in the development of venous thrombosis.

Methods: We performed a bidirectional two-sample Mendelian randomization analysis utilizing albumin genome-wide association study (GWAS) data alongside VTE datasets from various sources. Additionally, to minimize heterogeneity across different datasets, a meta-analysis of the Mendelian randomization results was conducted. Furthermore, genes associated with such exposures were identified to unravel how exposure impacts outcomes. This was followed by applying bioinformatics techniques for gene enrichment analysis and employing the Cytoscape software to pinpoint the hub genes.

Results: The findings from the meta-analysis of the Mendelian randomization indicate that reduced levels of albumin are associated with an elevated risk of VTE (OR = 0.739, 95% CI: 0.695 to 0.787, P = 1.82e-9), DVT (OR = 0.700, 95% CI: 0.646 to 0.772, P = 2.96e-15), and PE (OR = 0.717, 95% CI: 0.647 to 0.793, P = 1.74e-10). Bioinformatics analysis revealed that serum albumin primarily protects against VTE by influencing inflammation and cytokines.

Conclusions: Our bidirectional MR analysis confirmed a substantial causal association linking serum albumin to VTE. Bioinformatics analysis revealed that this causal link is mediated by the immune response through inflammation and cytokines.

References

Zhou T, Zhang Y, Wu P, Sun Q, Guo Y . Screening Feature Genes of Venous Thromboembolism with DNA Microarray. Chem Biol Drug Des. 2015; 86(4):821-8. DOI: 10.1111/cbdd.12557. View

Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

Sun Y, Deng J, Ding Y, Luo S, Li S, Guan Y . Serum albumin, genetic susceptibility, and risk of venous thromboembolism. Res Pract Thromb Haemost. 2024; 8(5):102509. PMC: 11364004. DOI: 10.1016/j.rpth.2024.102509. View

Kunutsor S, Makikallio T, Seidu S, de Araujo C, Dey R, Blom A . Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Eur J Epidemiol. 2019; 35(5):431-442. PMC: 7250794. DOI: 10.1007/s10654-019-00579-2. View

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

Valeriani E, Pannunzio A, Palumbo I, Bartimoccia S, Cammisotto V, Castellani V . Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients. J Thromb Haemost. 2024; 22(10):2823-2833. DOI: 10.1016/j.jtha.2024.06.018. View

Wang G, Zhao W, Yang Y, Yang G, Wei Z, Guo J . Identification of biomarkers of venous thromboembolism by bioinformatics analyses. Medicine (Baltimore). 2018; 97(14):e0152. PMC: 5902267. DOI: 10.1097/MD.0000000000010152. View

Xu X, Dong Y, Liu M, Li Y, Zhang Y . Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease. Nefrologia (Engl Ed). 2022; 41(5):548-555. DOI: 10.1016/j.nefroe.2021.11.009. View

10.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

11.

McInnes I, Thompson L, Giles J, Bathon J, Salmon J, Beaulieu A . Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2013; 74(4):694-702. PMC: 4392313. DOI: 10.1136/annrheumdis-2013-204345. View

12.

Yan A, Yip D, Peterson G, Samarawickrema I, Naunton M, Newman P . External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer. Cancers (Basel). 2024; 16(18). PMC: 11430721. DOI: 10.3390/cancers16183165. View

13.

Heinrich P, Castell J, Andus T . Interleukin-6 and the acute phase response. Biochem J. 1990; 265(3):621-36. PMC: 1133681. DOI: 10.1042/bj2650621. View

14.

Michel C, Curry F . Microvascular permeability. Physiol Rev. 1999; 79(3):703-61. DOI: 10.1152/physrev.1999.79.3.703. View

15.

Omar H, Mirsaeidi M, Rashad R, Hassaballa H, Enten G, Helal E . Association of Serum Albumin and Severity of Pulmonary Embolism. Medicina (Kaunas). 2020; 56(1). PMC: 7023373. DOI: 10.3390/medicina56010026. View

16.

Davies N, Holmes M, Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018; 362:k601. PMC: 6041728. DOI: 10.1136/bmj.k601. View

17.

Milford E, Reade M . Resuscitation Fluid Choices to Preserve the Endothelial Glycocalyx. Crit Care. 2019; 23(1):77. PMC: 6408751. DOI: 10.1186/s13054-019-2369-x. View

18.

Lutsey P, Zakai N . Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2022; 20(4):248-262. PMC: 9579604. DOI: 10.1038/s41569-022-00787-6. View

19.

Reitsma P, Versteeg H, Middeldorp S . Mechanistic view of risk factors for venous thromboembolism. Arterioscler Thromb Vasc Biol. 2012; 32(3):563-8. DOI: 10.1161/ATVBAHA.111.242818. View

20.

Burgess S, Scott R, Timpson N, Davey Smith G, Thompson S . Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015; 30(7):543-52. PMC: 4516908. DOI: 10.1007/s10654-015-0011-z. View